Reversal of Experimental Renal Fibrosis by BMP7 Provides Insights into Novel Therapeutic Strategies for Chronic Kidney Disease

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2008 May 1

PMID 18446379

Citations 34

Authors

Michael Zeisberg

Raghu Kalluri

Affiliations

Soon will be listed here.

Abstract

Bone morphogenic protein-7 (BMP7) is a morphogen that is important for kidney development and which is also an integral part of the kidney's physiological response to repair of acute kidney injury. Several studies demonstrate that preexisting renal BMP7 pathways can be utilized by administering recombinant BMP7 to protect the kidney in experimental models of chronic kidney disease (CKD). Effectiveness of recombinant BMP7 in animal studies raises the possibility that the BMP7 pathway could be equally utilized to treat patients with CKD and interstitial fibrosis. However, regulation of BMP7 activity in the kidney is complex. BMP7 activity in the kidney is not only determined by availability of BMP7 itself, but also by a balance of agonists, such as Kielin/chordin-like protein (KCP) or BMP receptors, and antagonists including gremlin, noggin, or uterine sensitization-associated gene-1 (USAG-1). Presence of BMP7 agonists and antagonists has to be considered when recombinant BMP7 is supplemented to treat injured kidneys. Here we summarize recent insights into the role of BMP7 in acute and chronic kidney injury and discuss the implications for future directions of antifibrotic therapies.

Citing Articles

curtails autoimmune nephritis via lasting bone marrow alterations, independent of hemozoin accumulation.

Amo L, Kole H, Scott B, Qi C, Krymskaya L, Wang H Front Immunol. 2023; 14:1192819.

PMID: 37539049 PMC: 10394379. DOI: 10.3389/fimmu.2023.1192819.

Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves' Orbitopathy.

Kim B, Choi S, Kim J, Ko J, In Yook J, Kim H Invest Ophthalmol Vis Sci. 2022; 63(6):7.

PMID: 35671049 PMC: 9187939. DOI: 10.1167/iovs.63.6.7.

Febuxostat inhibits TGF‑β1‑induced epithelial‑mesenchymal transition via downregulation of USAG‑1 expression in Madin‑Darby canine kidney cells in vitro.

Lu L, Zhu J, Zhang Y, Wang Y, Zhang S, Xia A Mol Med Rep. 2019; 19(3):1694-1704.

PMID: 30628645 PMC: 6390060. DOI: 10.3892/mmr.2019.9806.

High-throughput screens for agonists of bone morphogenetic protein (BMP) signaling identify potent benzoxazole compounds.

Bradford S, Ranghini E, Grimley E, Lee P, Dressler G J Biol Chem. 2019; 294(9):3125-3136.

PMID: 30602563 PMC: 6398139. DOI: 10.1074/jbc.RA118.006817.

Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.

Morine K, Qiao X, York S, Natov P, Paruchuri V, Zhang Y Circulation. 2018; 138(5):513-526.

PMID: 29487140 PMC: 6111008. DOI: 10.1161/CIRCULATIONAHA.117.031635.

References

Dolan V, Murphy M, Sadlier D, Lappin D, Doran P, Godson C . Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Am J Kidney Dis. 2005; 45(6):1034-9. DOI: 10.1053/j.ajkd.2005.03.014. View

Zeisberg M, Shah A, Kalluri R . Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem. 2004; 280(9):8094-100. DOI: 10.1074/jbc.M413102200. View

Martin P, Parkhurst S . Parallels between tissue repair and embryo morphogenesis. Development. 2004; 131(13):3021-34. DOI: 10.1242/dev.01253. View

Swencki-Underwood B, Mills J, Vennarini J, Boakye K, Luo J, Pomerantz S . Expression and characterization of a human BMP-7 variant with improved biochemical properties. Protein Expr Purif. 2007; 57(2):312-9. DOI: 10.1016/j.pep.2007.09.016. View

Wetzel P, Haag J, Campean V, Goldschmeding R, Atalla A, Amann K . Bone morphogenetic protein-7 expression and activity in the human adult normal kidney is predominantly localized to the distal nephron. Kidney Int. 2006; 70(4):717-23. DOI: 10.1038/sj.ki.5001653. View

Gould S, Day M, Jones S, Dorai H . BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int. 2002; 61(1):51-60. DOI: 10.1046/j.1523-1755.2002.00103.x. View

Sampath T, Maliakal J, Hauschka P, Jones W, Sasak H, Tucker R . Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem. 1992; 267(28):20352-62. View

Ducy P, Karsenty G . The family of bone morphogenetic proteins. Kidney Int. 2000; 57(6):2207-14. DOI: 10.1046/j.1523-1755.2000.00081.x. View

Zeisberg E, Tarnavski O, Zeisberg M, Dorfman A, McMullen J, Gustafsson E . Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007; 13(8):952-61. DOI: 10.1038/nm1613. View

10.

Bosukonda D, SHIH M, Sampath K, Vukicevic S . Characterization of receptors for osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat kidneys. Kidney Int. 2000; 58(5):1902-11. DOI: 10.1111/j.1523-1755.2000.00362.x. View

11.

Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F . BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med. 2003; 9(7):964-8. DOI: 10.1038/nm888. View

12.

Wang S, de Caestecker M, Kopp J, Mitu G, LaPage J, Hirschberg R . Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol. 2006; 17(9):2504-12. DOI: 10.1681/ASN.2006030278. View

13.

Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, Muller G . Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol. 2003; 285(6):F1060-7. DOI: 10.1152/ajprenal.00191.2002. View

14.

Zeisberg M . Bone morphogenic protein-7 and the kidney: current concepts and open questions. Nephrol Dial Transplant. 2005; 21(3):568-73. DOI: 10.1093/ndt/gfk010. View

15.

Rudnicki M, Eder S, Perco P, Enrich J, Scheiber K, Koppelstatter C . Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies. Kidney Int. 2006; 71(4):325-35. DOI: 10.1038/sj.ki.5002043. View

16.

Hogan B . Bone morphogenetic proteins in development. Curr Opin Genet Dev. 1996; 6(4):432-8. DOI: 10.1016/s0959-437x(96)80064-5. View

17.

Sugimoto H, Grahovac G, Zeisberg M, Kalluri R . Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes. 2007; 56(7):1825-33. DOI: 10.2337/db06-1226. View

18.

Lin J, Patel S, Cheng X, Cho E, Levitan I, Ullenbruch M . Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat Med. 2005; 11(4):387-93. DOI: 10.1038/nm1217. View

19.

Mitu G, Wang S, Hirschberg R . BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am J Physiol Renal Physiol. 2007; 293(5):F1641-8. DOI: 10.1152/ajprenal.00179.2007. View

20.

Hruska K, Guo G, Wozniak M, Martin D, Miller S, Liapis H . Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol. 2000; 279(1):F130-43. DOI: 10.1152/ajprenal.2000.279.1.F130. View